The Company’s headquarters is in Amsterdam, Netherlands and manages its global businesses through its two main German group companies; VSY Biotechnology Gmbh and Alsanza Medizintechnik und Pharma GmbH, delivering their products to more than 90 countries through their sales network. Development of innovative products through R&D activities is one its strategical priorities and its main focus is to create sustainable growth in all areas it operates in.
Overview
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 10, 2022 | Evmann Holding Searches For New Investment Opportunities in Eastern Europe | Evmann Investments Holding BV is currently exploring new investment and business opportunities in Eastern Europe. AMSTERDAM, THE NETHERLANDS, August 10, 2022 /EINPresswire.com/ -- Evmann Investments Holding BV, the umbrella organization of ... |
Reviews 0
FAQ about Evmann Investments Holding BV
What has the press written about Evmann Investments Holding BV?
Parsers VC has collected 2 articles mentioning Evmann Investments Holding BV, among them “Evmann Holding Searches For New Investment Opportunities in Eastern Europe” (Aug 10, 2022).
Is Evmann Investments Holding BV still active?
Yes, Evmann Investments Holding BV is active; its latest activity on Parsers VC dates from Feb 20, 2024.